1. Modulation of miR-382-5p reduces apoptosis of myocardial cells after acute myocardial infarction
    Liqin Zhang et al, 2021, Autoimmunity CrossRef
  2. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells
    Elīna Zandberga et al, 2017, Cancer Biology & Therapy CrossRef
  3. Integrative analyses of the mRNA expression profile reveal the involvement of STC1 in chicken folliculogenesis
    Junwei Sun et al, 2023, Journal of Animal Science CrossRef
  4. Alteration in the serum concentrations of FGF19, FGFR4 and βKlotho in patients with thyroid cancer
    Ewelina Motylewska et al, 2018, Cytokine CrossRef
  5. Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases
    Zhijun Han et al, 2022, Frontiers in Oncology CrossRef
  6. Delivery of BR2‐SOX17 fusion protein can inhibit cell survival, proliferation, and invasion in gastric cancer cells through regulating Klotho gene expression
    Lixia Yang et al, 2020, Cell Biology International CrossRef
  7. Klotho and the Treatment of Human Malignancies
    Aishani Sachdeva et al, 2020, Cancers CrossRef
  8. Overexpression of klotho suppresses growth and pulmonary metastasis of osteosarcoma in vivo
    Ying Li et al, 2020, Genetics and Molecular Biology CrossRef
  9. The Emerging Key Role of Klotho in the Hypothalamus–Pituitary–Ovarian Axis
    Tingting Xie et al, 2021, Reproductive Sciences CrossRef
  10. Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway
    Qiong Wu et al, 2021, Cancer Management and Research CrossRef
  11. Tissue expression and source of circulating αKlotho
    Hannes Olauson et al, 2017, Bone CrossRef
  12. Klotho in Cancer: Potential Diagnostic and Prognostic Applications
    Jucileide Mota et al, 2023, Diagnostics CrossRef
  13. Bruceine D and Narclasine inhibit the proliferation of breast cancer cells and the prediction of potential drug targets
    Xinhao Chen et al, 2024, PLOS ONE CrossRef
  14. Angiotensin II receptor type 1 blockade regulates Klotho expression to induce TSC2-deficient cell death
    Shikshya Shrestha et al, 2022, Journal of Biological Chemistry CrossRef
  15. Klotho suppresses tumor progression via inhibiting IGF-1R signaling in T-cell lymphoma
    Xiangxiang Zhou et al, 2017, Oncology Reports CrossRef
  16. Effects of Klotho on fibrosis and cancer: A renal focus on mechanisms and therapeutic strategies
    Rik Mencke et al, 2017, Advanced Drug Delivery Reviews CrossRef
  17. Expression, function and clinical application of stanniocalcin‐1 in cancer
    Fangyu Zhao et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
  18. Diagnostic and prognostic value of Stanniocalcin 1 expression in papillary thyroid cancer
    Sevinç Sengun et al, 2022, Endocrine CrossRef
  19. Klotho and aging phenotypes
    Marc G. Vervloet et al, 2021, Fibroblast Growth Factor 23 CrossRef
  20. Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer
    Bruna Pasqualotto Costa et al, 2020, Molecular and Cellular Endocrinology CrossRef
  21. Role of alpha and gamma Klotho genes in the development of differentiated thyroid carcinoma on top of goiter
    Wesam S. El-Saeed et al, 2022, Forum of Clinical Oncology CrossRef
  22. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells
    Xi Pan et al, 2017, Oncotarget CrossRef
  23. Association between klotho expression and malignancies risk and progression: A meta-analysis
    Song Mao et al, 2018, Clinica Chimica Acta CrossRef